3 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 1 | Unknown 1 |
Follow Antiviral Agents: new trials by email Literature Review of Antiviral Agents trials Research Report on Antiviral Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor), Remdesivir (antiviral) - COVID-19 | Phase 2 | Unknown | Lisa Barrett | 363 | 2020-04-17 | 2023-09-18 |
| Flufenamic Acid for Hospitalised Influenza Infection FFA, clarithromycin, oseltamivir, Oseltamivir alone - Influenza A | Phase 2 | Unknown | The University of Hong Kong | 200 | 2018-01-08 | 2019-10-22 |
| Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure Conventional plus BM-MSC treatment, Conventional plus UC-MSC treatment, Conventional treatment - Liver Failure | Phase 1 / Phase 2 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 210 | 2013-07-01 | 2013-07-08 |
COVID-19 (1) · Coronavirus Infections (1) · Influenza, Human (1) · Liver Failure (1)
Lisa Barrett (1) · The University of Hong Kong (1) · Third Affiliated Hospital, Sun Yat-Sen University (1)
Canada (1) · China (1) · Hong Kong (1)
Ivan Hung, MD FRCP (1) · Qi Zhang, Doctor (1)